hydroxycitric acid has been researched along with naltrexone in 1 studies
| Studies (hydroxycitric acid) | Trials (hydroxycitric acid) | Recent Studies (post-2010) (hydroxycitric acid) | Studies (naltrexone) | Trials (naltrexone) | Recent Studies (post-2010) (naltrexone) |
|---|---|---|---|---|---|
| 204 | 20 | 73 | 8,745 | 1,228 | 2,642 |
| Protein | Taxonomy | hydroxycitric acid (IC50) | naltrexone (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 1 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.0051 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0063 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.006 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.006 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.0319 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0093 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.0377 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.0076 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0004 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buhler, L; Icard, P; Lincet, H; Schwartz, L; Steyaert, JM | 1 |
1 other study(ies) available for hydroxycitric acid and naltrexone
| Article | Year |
|---|---|
Metabolic treatment of cancer: intermediate results of a prospective case series.
Topics: Adult; Aged; Citrates; Compassionate Use Trials; Female; Humans; Male; Middle Aged; Naltrexone; Neoplasms; Prospective Studies; Thioctic Acid; Vitamin B Complex | 2014 |